IPO Numbers Dipped In 2023, But 2024 Is Off To A Good Start

Funds Raised This Year Double The Like Period Last Year

 
• By Mandy Jackson

There were 21 biopharma initial public offerings in 2023, including J&J’s consumer health spin-out Kenvue, versus 22 in 2022. However, IPO proceeds are rising in 2024.

Initial public offering icon on dark background
The IPO market may rebound in 2024 from big dips in 2022 and 2023 • Source: Shutterstock

More from Financing

More from Business